Additional file 1 of GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer

Abstract

Additional file 1. Figure S1. Expression of GPRC5D in resectable and advanced tumors. Figure S2. Correlation between GPRC5D expression and (A) IPS and (B) immunomodulators. Figure S3. Expression of GPRC5D in tumors from responders and non-responders in other cancer types. Table S1. The baseline clinic-pathological features of two cohorts